AOD9604 5mg + Tesamorelin 5mg + MOTS-c 5mg

SKU: AOD5+TSM5+MS5

Laboratory Blend: AOD9604 5mg + Tesamorelin 5mg + MOTS-c 5mg – triple-action metabolic research blend.

Price range: $175.00 through $420.00

Packaging

Description

What is the AOD9604 + Tesamorelin + MOTS-c Blend?

This research blend combines three peptides with complementary mechanisms targeting fat metabolism, growth hormone release, and mitochondrial energy regulation. It is intended for advanced laboratory research into metabolic pathways and body composition models.

Blend Components

AOD9604 (5mg)	A stabilised fragment (177–191) of human growth hormone, studied for its role in lipolysis and fat metabolism without affecting IGF-1 or blood glucose.
Tesamorelin (5mg)	A GHRH analog that stimulates pituitary GH release; researched for visceral fat reduction and metabolic effects.
MOTS-c (5mg)	A mitochondria-derived peptide that activates AMPK and improves insulin sensitivity and metabolic homeostasis.

Blend Research Applications

1. Fat Metabolism and Lipolysis

AOD9604 activates beta-3 adrenergic receptors and may stimulate lipolysis and inhibit lipogenesis in adipose tissue models, providing a targeted fat-metabolism research tool.

2. Growth Hormone Axis Stimulation

Tesamorelin’s GHRH-analog activity promotes endogenous GH secretion, making this blend useful for studying the GH/IGF-1 axis alongside metabolic regulation.

3. Mitochondrial Metabolic Regulation

MOTS-c contributes AMPK-pathway activation, complementing the GH-axis effects of the other two peptides in combined metabolic research models.

Future Research

This combination blend is particularly relevant for research into visceral adiposity, metabolic syndrome, and growth hormone deficiency models in laboratory settings.

Resources

Heffernan MA, et al. – The effects of human GH fragment (177-191) on adipose tissue.
Falutz J, et al. – Tesamorelin and visceral adipose tissue reduction. NEJM, 2010.
Lee C, et al. – MOTS-c promotes metabolic homeostasis. Cell Metabolism, 2015.